View Author
patient cancer tumor pressure study volume expiration airway expiratory figure expression effect breathing treatment response level nsclc flow limitation tumour immunotherapy pemetrexed resistance survival mesothelioma disease rev respir dis ventilation macrophage ventilator model limitation tissue dendritic blood expiratory flow analysis inspiratory system measurement group opening increase journal end-expiratory toxicity curve chapter lysate respir number tumour-bearing mice lymph airway opening pressure trial celecoxib dendritic cells difference result peep-level table reduction grade inspiratory work mechanic therapy technique myeloid chemotherapy interruptor netherland airway opening culture lung volume compression ventilatory lung cancer injection non-small decrease value
10 Most Recent Publications
|
Generalizing lung-cancer screening results
(Article)
Heuvers, M.E. Stricker, B.H.Ch. Aerts, J.G.J.V. |
2012-01-12
|
|
Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy
(Article)
Hou, J. Lambers, M.E.H. Den Hamer, B. Bakker, M.A. den Hoogsteden, H.C. Grosveld, F.G. Hegmans, J.P. Aerts, J.G.J.V. Philipsen, S. |
2012-01-01
|
|
Integration of single-fiber reflectance spectroscopy into ultrasound-guided endoscopic lung cancer staging of mediastinal lymph nodes
(Article)
Kanick, S.C. Leest, K.H. van der Aerts, J.G.J.V. Hoogsteden, H.C. Kaščáková, S. Sterenborg, H.J.C.M. Amelink, A. |
2010-12-01
|
|
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies
(Article)
Surmont, V. Smit, E.F. Senan, S. Kraaij, C.J. Chouaki, N. Praag, J. Klaveren, R.J. van Jonge, M.J.A. de Aerts, J.G.J.V. Nackaerts, K. Vernhout, R. Gras, J. Wijk, A. van Phernambucq, E.C.J. Meerbeeck, J.P. van |
2010-09-01
|
|
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Hendriks, R.W. Hoogsteden, H.C. Aerts, J.G.J.V. Hegmans, J.P. |
2010-08-30
|
|
Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Hendriks, R.W. Hoogsteden, H.C. Hegmans, J.P. Aerts, J.G.J.V. |
2010-08-01
|
|
Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activitys
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Jong, S. de Hendriks, R.W. Hoogsteden, H.C. Aerts, J.G.J.V. Hegmans, J.P. |
2010-06-18
|
|
Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma
(Article)
Hegmans, J.P. Veltman, J.D. Lambers, M.E.H. Vries, I.J.M. de Figdor, C.G. Hendriks, R.W. Hoogsteden, H.C. Lambrecht, B.N.M. Aerts, J.G.J.V. |
2010-06-15
|
|
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer
(Article)
Surmont, V. Aerts, J.G.J.V. Klaveren, R.J. van Tournoy, K. Tan, K.Y. Vernhout, R. Schmitz, P.I.M. Legrand, C. Hoogsteden, H.C. Meerbeeck, J.P. van |
2010-06-01
|
|
A patient with four-year survival after nonsmall cell lung carcinoma with a solitary metachronous small bowel metastasis
(Article)
Kant, K.M. Noordhoek Hegt, V. Aerts, J.G.J.V. |
2010-05-06
|
